Pharmacokinetics, Safety, Tolerability of TEV-48125 in Healthy Subjects After Administration of TEV-48125

- Pharmacokinetics
- Completed

Study Title: To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects After a Single Subcutaneous (SC) Administration of TEV-48125

Teva Identifier: TV48125-PK-10078

ClinicalTrials.gov Identifier: NCT02673567

Study Status: Completed

Trial Condition(s): Pharmacokinetics

Interventions: Drug: TEV-48125 - 1 | Drug: TEV-48125 - 2 | Drug: TEV-48125 - 3 | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult

Age Range: 18 Years to 55 Years

Trial Duration: March 31, 2016 - February 10, 2017

Phase: Phase 1

Study Type

Interventional